In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Perindopril Erbumine Drug Master File in Korea (Perindopril Erbumine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Perindopril Erbumine. The MFDS reviews the Perindopril Erbumine KDMF as part of the drug registration process and uses the information provided in the Perindopril Erbumine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Perindopril Erbumine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Perindopril Erbumine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Perindopril Erbumine suppliers with KDMF on PharmaCompass.